Association of Acute Interstitial Nephritis With Programmed Cell Death 1 Inhibitor Therapy in Lung Cancer Patients.
暂无分享,去创建一个
[1] F. Hodi,et al. Anti-PD-1-Related Pneumonitis during Cancer Immunotherapy. , 2015, The New England journal of medicine.
[2] L. Crinò,et al. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. , 2015, The New England journal of medicine.
[3] C. Porta,et al. Renal effects of targeted anticancer therapies , 2015, Nature Reviews Nephrology.
[4] J. Lunceford,et al. Pembrolizumab for the treatment of non-small-cell lung cancer. , 2015, The New England journal of medicine.
[5] S. Gettinger,et al. Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy , 2015, Diabetes Care.
[6] C. Robert,et al. Kidney injuries related to ipilimumab , 2014, Investigational New Drugs.
[7] Antoni Ribas,et al. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. , 2013, The New England journal of medicine.
[8] C. Berking,et al. The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network , 2013, PloS one.
[9] David C. Smith,et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.
[10] Loise M. Francisco,et al. The PD‐1 pathway in tolerance and autoimmunity , 2010, Immunological reviews.
[11] B. Knebelmann,et al. Anti-CTLA4 antibody-induced lupus nephritis. , 2009, The New England journal of medicine.
[12] R. Wüthrich,et al. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] M. Britschgi,et al. Involvement of drug-specific T cells in acute drug-induced interstitial nephritis. , 2006, Journal of the American Society of Nephrology : JASN.
[14] A. Webster,et al. Proton pump inhibitors and acute interstitial nephritis. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[15] J. Rossant,et al. Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. , 2006, Journal of the American Society of Nephrology : JASN.
[16] G. Freeman,et al. Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation , 2000, The Journal of experimental medicine.
[17] G. Zhu,et al. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion , 1999, Nature Medicine.
[18] T. Honjo,et al. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. , 1999, Immunity.